Medical Properties Trust price target raised to $9 from $8 at Truist

Truist raised the firm’s price target on Medical Properties Trust to $9 from $8 and keeps a Hold rating on the shares. The company is selling its Australian hospitals for essentially the same amount as the associated debt, which is pulling the earnings dilution that was expected to be realized in 2024 up a few quarters earlier, the analyst tells investors in a research note.